<DOC>
	<DOCNO>NCT02060201</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence ( BE ) Saxagliptin Dapagliflozin 2.5-mg Saxagliptin/5-mg Dapagliflozin FDC tablet oral administration relative 2.5-mg Saxagliptin 5-mg Dapagliflozin tablet administer orally together fasted state demonstrate BE Saxagliptin Dapagliflozin 5-mg Saxagliptin/10-mg Dapagliflozin FDC tablet oral administration relative 5-mg Saxagliptin 10-mg Dapagliflozin tablet administer orally together fasted state . Demonstrating bioequivalence refers show FDC tablet co-administration individual component yield similar blood levels/concentrations drug handle body similarly .</brief_summary>
	<brief_title>Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination ( FDC )</brief_title>
	<detailed_description>Primary Purpose : This study design demonstrate bioequivalence Saxagliptin Dapagliflozin FDC tablet oral administration relative Saxagliptin Dapagliflozin tablet administer orally together fast fed state</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject determine clinically significant deviation normal medical history , physical examination ( PE ) , vital sign , 12lead ECG , clinical laboratory determination Body mass index ( BMI ) 18.5 30 kg/m ( 2 ) Men woman , age 18 50 year Women childbearing potential must use acceptable method highly effective birth control Any significant acute chronic medical illness Current recent gastrointestinal disease Any major surgery within 4 week study drug administration History chronic recurrent urinary tract infection females History glucose intolerance diabetes mellitus History allergy adverse reaction Dipeptidyl peptidaseIV ( DPP4 ) Sodiumglucose cotransporter ( SGLT ) inhibitor Prior exposure Saxagliptin Dapagliflozin relate drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>